Ipsen Pharma Biotech SAS
PolandAll drugs from this manufacturer
-
The medicine is used in the treatment of metastatic prostate cancer and in the treatment of infertility in women (as adjuvant treatment during preparation for assisted reproduction).
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage triptorelin 0.1 mg ATC: L02AE04
-
The medicine is used for the treatment of prostate cancer (to lower testosterone levels) and in children in cases of precocious puberty (before age 8 in girls and before age 10 in boys).
Dosage form: powder and solvent for preparation of suspension for injection with prolonged release
Active substance Dosage triptorelin 15 mg ATC: L02AE04
-
In adult men, it is used for the treatment of prostate cancer (with metastases or high risk of recurrence). In children over 2 years of age, the medicine is used for the treatment of precocious puberty.
Dosage form: powder and solvent for preparation of suspension for injection with prolonged release
Active substance Dosage triptorelin embonate 31 mg ATC: L02AE04
-
The medicine is used in the treatment of prostate cancer, breast cancer in women, endometriosis, uterine leiomyomas, and in the treatment of infertility in women. It is also used in cases of precocious puberty in children.
Dosage form: powder and solvent for preparation of suspension for injection with prolonged release
Active substance Dosage triptorelin acetate 4.2 mg ATC: L02AE04
-
The medicine is used to reduce sexual drive in adult men with severe sexual deviations.
Dosage form: powder and solvent for preparation of suspension for injection with prolonged release
Active substance Dosage triptorelin embonate No input provided ATC: L02AE04
-
The medicine is used for the long-term treatment of acromegaly (excessive secretion of growth hormone) and to relieve symptoms associated with this disease, such as headaches, fatigue, or joint pain. It is also used in the treatment and inhibition of growth of certain advanced neuroendocrine tumors in the intestines and pancreas, and to relieve symptoms (e.g., hot flashes and diarrhea) in patients with neuroendocrine tumors.
Dosage form: solution for injection
Active substance Dosage lanreotide acetate 79.8 mg ATC: H01CB03
-
The medicine is used for the long-term treatment of acromegaly (a condition of excess growth hormone) and to relieve its symptoms, such as headaches, fatigue, or joint pain. It is also used in the treatment and inhibition of growth of certain advanced neuroendocrine tumors in the intestines and pancreas, and to relieve symptoms (e.g., hot flashes and diarrhea) associated with these tumors.
Dosage form: solution for injection
Active substance Dosage lanreotide acetate 116.4 mg ATC: H01CB03
-
The medicine is used for the long-term treatment of acromegaly (to reduce excess growth hormone and alleviate its symptoms, such as headaches or fatigue) and for the treatment and inhibition of growth of certain advanced neuroendocrine tumors in the intestine and pancreas (when they cannot be surgically removed). It also helps to alleviate hot flashes and diarrhea in patients with neuroendocrine tumors.
Dosage form: solution for injection
Active substance Dosage lanreotide acetate 155.45 mg ATC: H01CB03